Nordea Bank AB (publ)

  • ISIN: FR0124068745
  • Land: .

Nachricht vom 12.09.2017 | 13:07

Nordea's nomination committee appointed

DGAP-News: Nordea Bank AB (publ) / Key word(s): Miscellaneous

12.09.2017 / 13:07
The issuer is solely responsible for the content of this announcement.

COPENHAGEN, DENMARK -- (Marketwired) -- 09/12/17 -- The Nordea Bank


Nordea's nomination committee for the Annual General Meeting 2018

Nordea's Annual General Meeting 2017 decided to establish a
nomination committee with the task of presenting to the Annual
General Meeting 2018 proposals concerning election of members of the
board of directors, chairman of the board of directors and auditors,
as well as fees to the board members and auditors.

The four largest shareholders in terms of votes who wish to
participate in the nomination committee are entitled to appoint one
member each. In addition, the chairman of the board of directors
participates in the nomination committee.

The members of the nomination committee are:
Torbjoern Magnusson, Managing Director of If, appointed by Sampo Abp
Mogens Hugo, Chairman of Nordea-fonden
Katarina Thorslund, Deputy CEO and Head of Customer Relations at
Anders Oscarsson, Head of Equity at AMF and AMF Funds
Bjoern Wahlroos, Chairman of the Board of Directors

Torbjoern Magnusson has been appointed chairman of the nomination

The Annual General Meeting will be held on Thursday 15 March 2018.

Shareholders who wish to submit a proposal to the nomination
committee must do this in writing no later than 31 December 2017 to
Nordea's website or the following address:
Nordea Bank AB (publ)
The Nomination Committee
c/o Group Legal, H 50
SE-105 71 Stockholm

For further information:
Torbjoern Magnusson, +46 8 792 81 12

12.09.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

show this

News im Fokus

BASF SE: Ergebnis steigt im Geschäftsjahr 2017 deutlich und übertrifft Analystenschätzungen erheblich

18. Januar 2018, 16:49

Aktuelle Research-Studie

Original-Research: PHARMING (von First Berlin Equity Research GmbH): BUY PHARMING

18. Januar 2018